Recent research has highlighted the connection between antidepressant use and menstrual disorders in women. A study involving 1432 women from various medical centers found that those taking antidepressants experienced a notably higher incidence of menstrual disorders, with rates of 24.6% in the treated group compared to 12.2% in the control group. Among the antidepressants studied, certain medications such as Paroxetine, Venlafaxine, and Sertraline were the most implicated, raising concerns over their effects on women's reproductive health. The results also indicated that 14.5% of women in the antidepressant group reported antidepressant-induced menstrual disorders, emphasizing the need for healthcare providers to consider these potential side effects when prescribing treatment. It is crucial for women experiencing such issues to communicate openly with their healthcare professionals to explore alternatives or adjustments in their treatment plans. Understanding the implications of medication on health is vital, as it empowers patients to make informed decisions. Furthermore, as this research gains attention, it may lead to deeper discussions regarding the need for further studies on the long-term effects of antidepressants on women's health, paving the way for improved treatment protocols and better overall care for those affected by mental health disorders.